Dopamine Hydrochloride Injection, Solution, Concentrate
Product Images NDC 0409-9104

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride (NDC 0409-9104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Dopamine (Image 01)

Chemical structure of Dopamine Hydrochloride, depicting a benzene ring with two hydroxyl groups and an ethylamine side chain bound to hydrochloride (HCl).*

FDA Label Image

Hospira Logo (Hospira Logo)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for DOPamine Hydrochloride Injection USP, 200 mg per 5 mL (40 mg/mL) concentrate solution for intravenous use. The single-dose 5 mL vial label includes caution that the product must be diluted for intravenous use, a note on stabilizers and buffers, NDC 0409-5820-11, and distribution by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (5 mL Vial Tray)

Packaging label for DOPamine Hydrochloride Injection, USP, 200 mg/5 mL (40 mg/mL) solution concentrate for intravenous use. The 5 mL single-dose fliptop vial label includes dosage strength, a caution that it must be diluted, manufacturer Hospira, Inc., storage instructions, and ingredient information. The label also notes it contains no bacteriostat and must be used promptly after dilution.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for DOPamine Hydrochloride injection, USP, 40 mg/mL (400 mg/10 mL) single-dose concentrate for intravenous use. The 10 mL vial contains a solution requiring dilution. Distributed by Hospira, Inc., Lake Forest, IL. Contains stabilizers including sodium metabisulfite, citric acid, and sodium citrate as buffers.*

FDA Label Image

Principal Display Panel (10 mL Vial Tray)

Packaging label for DOPamine Hydrochloride Injection, USP 400 mg/10 mL (40 mg/mL) concentrate solution for intravenous use, supplied in a 10 mL single-dose fliptop vial. The label includes caution that the product must be diluted prior to use. It is labeled for prescription use only and manufactured by Hospira, Inc., with storage instructions and ingredient information visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.